Netherlands · Story · Companies
Philips faces legal challenges over sleep apnea devices
Philips has faced legal scrutiny over its sleep apnea devices, with a court denying further investigation and a settlement reached with the U.S. Department of Justice.
Running story — the local press covered it again on 3 November 2026.
The story so far as of 3 November 2026
On October 10, 2026, a Dutch court denied requests for a deeper investigation into Philips' involvement in the 2021 sleep apnea device recall. Investors sought an inquiry into Philips' handling of the situation, but the court ruled against it. On November 3, 2026, Philips reached a preliminary agreement to settle a legal issue with the U.S. Department of Justice, setting aside €288 million for the settlement, which impacted its third-quarter earnings.
Flare-up watch: Calm (0.1) · Active flag: Heightened vigilance for staff and travel · How this is judged → · All Netherlands briefings →
Coverage, day by day
- Companies
Philips settles sleep apnea case for €288 million
Impact Philips' financial stability is affected by the settlement cost, impacting investors.
Sources: Telegraaf.nl ↗, NOS.nl ↗
- Regulation
Court denies further probe into Philips sleep apnea case
Impact Philips' shareholders and investors face no new regulatory scrutiny from this ruling, maintaining current business conditions.
Sources: NU.nl ↗, Omroep Brabant ↗
Sources in this story
Sources: each headline links to the original article on the publisher's site.